Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency

W. Ruitenbeek, P. J E Poels, D. M. Turnbull, B. Garavaglia, R. A. Chalmers, R. W. Taylor, F. J M Gabreels

Research output: Contribution to journalArticle

Abstract

A previously asymptomatic 30 year old man presented with rhabdomyolysis, muscle weakness, and acute encephalopathy after strenuous exertion in the cold without adequate food intake. Serum and muscle carnitine concentrations were decreased. Urinary excretion of carnitine and glycine esters and biochemical examination of skeletal muscle and fibroblasts led to the diagnosis of medium chain acyl-CoA dehydrogenase (MCAD) deficiency. A point mutation at nucleotide position 985 of the coding region of the MCAD gene was found. The ;MCAD protein was synthesised in the patient's fibroblasts at a normal rate, but was unstable. In general, patients in whom the 985 point mutation has been established show much more severe clinical symptoms and other symptoms than those seen in this patient. The relation of the 985 point mutation and the residual MCAD activity to the symptoms is not as straightforward as previously thought.

Original languageEnglish
Pages (from-to)209-214
Number of pages6
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume58
Issue number2
Publication statusPublished - 1995

Fingerprint

Acyl-CoA Dehydrogenase
Rhabdomyolysis
Brain Diseases
Point Mutation
Carnitine
Fibroblasts
Muscle Weakness
Glycine
Esters
Skeletal Muscle
Nucleotides
Eating
Muscles
Serum
Genes
Medium chain acyl CoA dehydrogenase deficiency
Proteins

Keywords

  • Encephalopathy
  • Medium chain acyl-CoA dehydrogenase deficiency
  • Rhabdomyolysis

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology

Cite this

Ruitenbeek, W., Poels, P. J. E., Turnbull, D. M., Garavaglia, B., Chalmers, R. A., Taylor, R. W., & Gabreels, F. J. M. (1995). Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency. Journal of Neurology, Neurosurgery and Psychiatry, 58(2), 209-214.

Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency. / Ruitenbeek, W.; Poels, P. J E; Turnbull, D. M.; Garavaglia, B.; Chalmers, R. A.; Taylor, R. W.; Gabreels, F. J M.

In: Journal of Neurology, Neurosurgery and Psychiatry, Vol. 58, No. 2, 1995, p. 209-214.

Research output: Contribution to journalArticle

Ruitenbeek, W, Poels, PJE, Turnbull, DM, Garavaglia, B, Chalmers, RA, Taylor, RW & Gabreels, FJM 1995, 'Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency', Journal of Neurology, Neurosurgery and Psychiatry, vol. 58, no. 2, pp. 209-214.
Ruitenbeek, W. ; Poels, P. J E ; Turnbull, D. M. ; Garavaglia, B. ; Chalmers, R. A. ; Taylor, R. W. ; Gabreels, F. J M. / Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency. In: Journal of Neurology, Neurosurgery and Psychiatry. 1995 ; Vol. 58, No. 2. pp. 209-214.
@article{06605aec90ad42e98b582d5c9b913fcb,
title = "Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency",
abstract = "A previously asymptomatic 30 year old man presented with rhabdomyolysis, muscle weakness, and acute encephalopathy after strenuous exertion in the cold without adequate food intake. Serum and muscle carnitine concentrations were decreased. Urinary excretion of carnitine and glycine esters and biochemical examination of skeletal muscle and fibroblasts led to the diagnosis of medium chain acyl-CoA dehydrogenase (MCAD) deficiency. A point mutation at nucleotide position 985 of the coding region of the MCAD gene was found. The ;MCAD protein was synthesised in the patient's fibroblasts at a normal rate, but was unstable. In general, patients in whom the 985 point mutation has been established show much more severe clinical symptoms and other symptoms than those seen in this patient. The relation of the 985 point mutation and the residual MCAD activity to the symptoms is not as straightforward as previously thought.",
keywords = "Encephalopathy, Medium chain acyl-CoA dehydrogenase deficiency, Rhabdomyolysis",
author = "W. Ruitenbeek and Poels, {P. J E} and Turnbull, {D. M.} and B. Garavaglia and Chalmers, {R. A.} and Taylor, {R. W.} and Gabreels, {F. J M}",
year = "1995",
language = "English",
volume = "58",
pages = "209--214",
journal = "Journal of Neurology, Neurosurgery and Psychiatry",
issn = "0022-3050",
publisher = "BMJ Publishing Group",
number = "2",

}

TY - JOUR

T1 - Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency

AU - Ruitenbeek, W.

AU - Poels, P. J E

AU - Turnbull, D. M.

AU - Garavaglia, B.

AU - Chalmers, R. A.

AU - Taylor, R. W.

AU - Gabreels, F. J M

PY - 1995

Y1 - 1995

N2 - A previously asymptomatic 30 year old man presented with rhabdomyolysis, muscle weakness, and acute encephalopathy after strenuous exertion in the cold without adequate food intake. Serum and muscle carnitine concentrations were decreased. Urinary excretion of carnitine and glycine esters and biochemical examination of skeletal muscle and fibroblasts led to the diagnosis of medium chain acyl-CoA dehydrogenase (MCAD) deficiency. A point mutation at nucleotide position 985 of the coding region of the MCAD gene was found. The ;MCAD protein was synthesised in the patient's fibroblasts at a normal rate, but was unstable. In general, patients in whom the 985 point mutation has been established show much more severe clinical symptoms and other symptoms than those seen in this patient. The relation of the 985 point mutation and the residual MCAD activity to the symptoms is not as straightforward as previously thought.

AB - A previously asymptomatic 30 year old man presented with rhabdomyolysis, muscle weakness, and acute encephalopathy after strenuous exertion in the cold without adequate food intake. Serum and muscle carnitine concentrations were decreased. Urinary excretion of carnitine and glycine esters and biochemical examination of skeletal muscle and fibroblasts led to the diagnosis of medium chain acyl-CoA dehydrogenase (MCAD) deficiency. A point mutation at nucleotide position 985 of the coding region of the MCAD gene was found. The ;MCAD protein was synthesised in the patient's fibroblasts at a normal rate, but was unstable. In general, patients in whom the 985 point mutation has been established show much more severe clinical symptoms and other symptoms than those seen in this patient. The relation of the 985 point mutation and the residual MCAD activity to the symptoms is not as straightforward as previously thought.

KW - Encephalopathy

KW - Medium chain acyl-CoA dehydrogenase deficiency

KW - Rhabdomyolysis

UR - http://www.scopus.com/inward/record.url?scp=0028949363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028949363&partnerID=8YFLogxK

M3 - Article

C2 - 7876853

AN - SCOPUS:0028949363

VL - 58

SP - 209

EP - 214

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

SN - 0022-3050

IS - 2

ER -